(Q37252833)

19 August 2017

Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort (English)

1 reference

19 August 2017

0 references

Christopher W Teshima

1

0 references

author name string

Adrienne Thompson

2

1 reference

19 August 2017

LeRose Dhanoa

3

1 reference

19 August 2017

Levinus A Dieleman

4

1 reference

19 August 2017

Richard N Fedorak

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

Canadian Journal of Gastroenterology

19 August 2017

0 references

volume

23

1 reference

19 August 2017

5

1 reference

19 August 2017

348-352

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

19 August 2017

start time

1 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Infliximab maintenance therapy for fistulizing Crohn's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Infliximab for the treatment of fistulas in patients with Crohn's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Austrian infliximab experience in Crohn's disease: a nationwide cooperative study with long-term follow-up

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706747

Infliximab in Crohn's disease: first anniversary clinical experience

3 September 2018

1 reference

12 December 2020

Infliximab treatment for Crohn's disease: one-year experience in a Dutch academic hospital

1 reference

12 December 2020

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

1 reference

12 December 2020

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

12 December 2020

Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease

1 reference

12 December 2020

Development of a Crohn's index for survey research

1 reference

12 December 2020

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

1 reference

12 December 2020

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

1 reference

12 December 2020

Long-term durability of Crohn's disease treatment with infliximab

1 reference

12 December 2020

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

1 reference

12 December 2020

Identifiers

DOI

10.1155/2009/180840

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19440565

1 reference